Company Overview and News

358
Jane's May Dividend Income Tracker - Retirement Accounts

5h seekingalpha
This is the third month I have officially tracked dividend income (in an article) for Jane's Traditional and Roth IRA Accounts. Her dividend income totaled $891.57.
GIS O.PRF WBA ENB OPRF JCI HSY ABBV MMM POL MO SMG IRET.PR DUKH GD IRET.PRC TRV IRET.PRB GPT.PRB MAIN BX CMI ENB RY BNS JNJ TROW GPT VZ ABBV MSFT WPC ADM PFE CLX PM PFBC SKT SCL CTL IRET OXLCM OXLCO TD ETN OXLCN BNS CM MSCA GPT.PRA INTC TD IBM IRET.PRCL RY TNTTF LYB O MSB DUK SNX OXLC IRM MSCA.CL EMRAF ORI PPL BMRC DLR CBL

213
CenturyLink Is A Great Value Play That Pays You 12% To Wait

16h seekingalpha
There is light at the end of the tunnel because of new leadership, commitment to the dividend, and a new profit growth engine.
STT IVV BLK STT.PRC STT.PRE STT.PRD VRX STT.PRG CTL VYM IVV

269
4 Predictions For The Next Media-Telecom Megamerger

2018-06-18 seekingalpha
Now that AT&T-Time Warner acquisition was approved by Judge Leon, many expect more consolidation to follow.
BABA CHTR FB T CMCSA TWX VZ CTL NFLX TWC DIS

60
Will Rising Rates Derail This 11.95% Yielding REIT?

2018-06-16 seekingalpha
The Fed Chair is very sanguine on the outlook for the U.S. economy going forward, supporting his intent to proffer two more raises this year.
SOJA GEO EPR.PRG O.PRF CTL LTC BATS 4162 OPRF SUI.PRA VZA SUI MSCA HMNY ED MO GOV SO ARCC O MAIN RMR GOVNI ARU MSCA.CL VGR ROKU CLDT VZ WPC OHI

25
S&P Ultra Dividend Revenue ETF: 5.36% Yield

2018-06-13 seekingalpha
This ETF has a unique revenue weighted investment strategy and offers investors exposure to a diversified portfolio of high-yield stocks.
CTL M

64
Top Consumer Company Near 52-Week Low Yields 5.89%: Seeks Redemption In India

2018-06-13 seekingalpha
Anyone paying even the least amount of attention to the tobacco industry is cognizant of the fact that Philip Morris (PM) is putting a full-court press on getting its IQOS smokeless product to surpass, supplant and replace tobacco products like cigarettes.
SOJA PM GEO EPR.PRG O.PRF CTL LTC BATS 4162 OPRF SUI.PRA VZA SUI MSCA HMNY ED MO GOV SO ARCC O MAIN RMR GOVNI ARU MSCA.CL VGR NDAQ ROKU CLDT VZ WPC OHI

56
Little Rocket Man: 'Great Personality'!

2018-06-13 seekingalpha
When sanity and reality returns, investors will flock back into the likes of Boeing, Raytheon and Lockheed Martin for safety, capital appreciation and income.
SOJA LMT GEO EPR.PRG O.PRF CTL LTC BATS 4162 OPRF SUI.PRA VZA SUI MSCA ED MO GOV SO ARCC O MAIN RMR GOVNI ARU MSCA.CL VGR ROKU CLDT VZ WPC OHI

23
CenturyLink (CTL) Supports Google Cloud Partner Interconnect

2018-06-12 zacks
CenturyLink, Inc. (CTL - Free Report) recently announced that it has joined forces with Google Cloud Partner Interconnect, a suite of cloud computing services by Alphabet Inc. (GOOGL - Free Report) . Partner Interconnect provides connectivity between on-premises network and virtual private cloud network through a supported service provider, enabling customers to connect to Google Cloud Platform globally.
HOCPY GOOGL GRMN CTL GOOG

6
CenturyLink: Strategy Has Merits

2018-06-12 seekingalpha
To state that CenturyLink (CTL) stock has had a bad year is to state it mildly. Its stock has performed badly when the broader market has done well. The company is struggling to grow revenue and profitability in a highly competitive market. What can current, and future shareholders look forward to in the company? What is the strategy laid out by the company for revenue and profitability growth? Does that strategy hold merit? What are some things that current and future shareholders can look-out for as signs of positive progress at the company?
CTL

116
My Conversation With Harry

2018-06-08 seekingalpha
I have two people that influenced how I invest. One, I make sure I call or visit him once a month.
SOJA SO GE CTL ASIX BRK.A TGT HON GM.WS.A GM.WS.B GM.WS.C GM FL GM.WSB CLX

23
Why Is CenturyLink (CTL) Down 2.5% Since its Last Earnings Report?

2018-06-08 zacks
A month has gone by since the last earnings report for CenturyLink, Inc. (CTL - Free Report) . Shares have lost about 2.5% in that time frame.
UNP CTL ATUS

8
CTL / CenturyLink, Inc. 8-K (Current Report)

2018-06-07 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549
CTL

81
CenturyLink (CTL) Secures 2-Year ISP Contract From Quilt

2018-06-07 zacks
CenturyLink, Inc. (CTL - Free Report) recently secured a two-year contract as an authorized commercial Internet service provider (ISP) from The Quilt, a national coalition of non-profit regional networks for research and education across the United States. Quilt represents 40 networks across the country and provides advanced network services and applications to more than 900 universities and thousands of other educational institutions.
MSI CTL UBNT BB BB BBRY

79
Comcast: Here To Stay, Diversified Or Not

2018-06-05 seekingalpha
Internet penetration rates are the key to valuing a cable or telecom provider. Video take rates will be meaningless in the long run.
FOX CMCSA CTL FOXA ATUS

78
Broadband Leaders Push Back on Proposed Ban on ZTE, Huawei Gear - Bloomberg

2018-06-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VZ CTL MSFT INTC QCOM VZA

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to CTL / CenturyLink, Inc. on message board site Silicon Investor.

Strictly: Drilling and oil-field services Anti-Capitalist Protesters: What do they want, exactly?
Strictly: Drilling II Strictly Buy and Sell Set Ups
Actel [ACTL] Strictly: Oil and Gas Exploration Companies
Strictly ..... Bottom Fishing CTLH COURTLEIGH CAPITAL
Strictly Drilling Strictly Off Topic
CUSIP: 156700106